Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi launches French eHealth laboratory 39BIS

The digital lab will focus on its home market and is based near Paris

Sanofi 39BIS digital laboratory France

Sanofi has launched a ‘digital laboratory’ just outside Paris that will be dedicated to advancing its eHealth work in France.

Known as 39BIS, the lab is a first for both the French pharma company and its home country. It aims to connect Sanofi employees with representatives from a wide variety of other companies and stakeholders within the eHealth environment.

Sanofi’s country chair for France Guillaume Leroy said: “"We are convinced that e-health will make a significant contribution to changing our healthcare system and improving patient care.

“We are proud to make available to everyone 39BIS, a unique place to accelerate the development of e-solutions for healthcare professionals and patients in their life course.”

Sanofi’s eHealth strategy in France is focused on healthcare professionals - including dispensing pharmacists - and medicines, pharmacovigilance, skin disorder diagnosis and exploring diagnostics in rare diseases and vaccines.

As part of its efforts to develop eHealth solutions the firm aims to harness areas such as connected objects, big data, block chain, serious games and artificial intelligence.

Dmd Santé, France eHealth Tech and Umanlife are among the laboratory’s initial external partners and its offering will include a six-month project process.

Isabelle Vitali, director innovation and business excellence at Sanofi France, characterised the space as “a place of daring where one has the right to explore, to experiment or even to err in order to advance”.

Leroy said earlier this year: “In e-health, we are only at the beginning, but the potential is enormous. In France, we already offer e-solutions in our areas of expertise, such as cardiovascular diseases, rare diseases and pain management.

“In diabetes, Sanofi has developed several mobile applications as well as a telemedicine solution that has received a positive opinion for reimbursement in France.”

39BIS is located at the Sanofi’s Val de Bièvre campus just south of Paris in Gentilly, where it offers a showroom, a co-creation ideation space and a prototyping area.

“With this location, we will be able to anchor Sanofi’s digital strategy and interact increasingly with the ecosystem, including startups, schools, incubators and large companies,” Leroy said.

“The 39BIS will offer a scalable offer of services and training to accelerate our ambitions in e-health. It is an important new step in our strong commitment to digital health.”

12th December 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Real patient voices
The #Human behind every number project...
translational pharmacology medicine dose
The gold standard of scientific evidence
Will randomised controlled trials become a thing of the past?...
What does programmatic advertising mean for your pharma marketing strategy?
Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns....

Infographics